|
1
|
Koyfman SA, Ismaila N, Holsinger FC. Reply to C. Schilling et al. J Oncol Pract 2019; 15:561. [PMID: 31513479 DOI: 10.1200/jop.19.00434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Shlomo A Koyfman
- Shlomo A. Koyfman, MD, Cleveland Clinic, Cleveland, OH; Nofisat Ismaila, MD, American Society of Clinical Oncology, Alexandria, VA; and F. Christopher Holsinger, MD, Stanford University, Palo Alto, CA
| | - Nofisat Ismaila
- Shlomo A. Koyfman, MD, Cleveland Clinic, Cleveland, OH; Nofisat Ismaila, MD, American Society of Clinical Oncology, Alexandria, VA; and F. Christopher Holsinger, MD, Stanford University, Palo Alto, CA
| | - F Christopher Holsinger
- Shlomo A. Koyfman, MD, Cleveland Clinic, Cleveland, OH; Nofisat Ismaila, MD, American Society of Clinical Oncology, Alexandria, VA; and F. Christopher Holsinger, MD, Stanford University, Palo Alto, CA
| |
Collapse
|